Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II Clinical Study of E7389 for Advanced or Relapsed Breast Cancer.

Trial Profile

Phase II Clinical Study of E7389 for Advanced or Relapsed Breast Cancer.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 19 Aug 2013

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Eribulin (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Most Recent Events

    • 19 Aug 2013 Start and end dates of the extension trial amended as reported by ClinicalTrials.gov. Changed from Aug 2009 - Nov 2010 to Jan 2008 - Jan 2011.
    • 19 Aug 2013 Start and end dates of the extension trial amended as reported by ClinicalTrials.gov. Changed from Aug 2009 - Nov 2010 to Jan 2008 - Jan 2011.
    • 11 Oct 2011 Actual end date of the extension trial (NCT00965523) is Nov 2010.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top